mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.008 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |